[Can gastroduodenal lesions induced by non-steroidal anti-inflammatory agents be prevented?].
Florent
C
C
Hôpital Saint-Antoine, Paris.
Florent
M
M
Desaint
B
B
D000863:Antacids / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004378:Duodenal Diseases / Q000139:chemically induced* / Q000517:prevention & control; D005756:Gastritis / Q000139:chemically induced / Q000517:prevention & control; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced / Q000517:prevention & control; D011453:Prostaglandins / Q000627:therapeutic use; D013392:Sucralfate / Q000627:therapeutic use
D000863:Antacids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D005765:Gastrointestinal Agents; D011453:Prostaglandins; D013392:Sucralfate
Peut-on prévenir les lésions gastro-duodénales induites par les anti-inflammatoires non stéroïdiens?